Advertisement

Topics

Companies Related to "VNS Prospective Neuromodulation of Autonomic, Immune and Gastrointestinal Systems" [Most Relevant Company Matches] RSS

04:07 EDT 25th June 2019 | BioPortfolio

Here are the most relevant search results for "VNS Prospective Neuromodulation of Autonomic, Immune and Gastrointestinal Systems" found in our extensive corporate database of over 50,000 company records.

Showing "Prospective Neuromodulation Autonomic Immune Gastrointestinal Systems" Companies 1–25 of 4,500+

Relevant

Advanced Neuromodulation Systems Incorporated ANS

Advanced Neuromodulation Systems, Inc. (NASDAQ: ANSI) is an exciting, high-technology medical device company that is at the center of the dynamic and explosively growing neuromodulation market.Neuromodulation is a medical therapy used to treat disabling chronic pain and nervous system disorders. The term “neuromodulation” refers to the delivery of electrical stimulation or drugs directly to ta...


Advanced Neuromodulation Systems

Welcome to Advanced Neuromodulation Systems Successful treatment of a chronic pain or neurological condition begins with expanding your knowledge and exploring your options.Welcome to Advanced Neuromodulation Systems where our neurostimulation and drug pump technologies are advancing treatment standards for chronic pain and neurological disorders, broadening treatment choices for patients and phys...

North American Neuromodulation Society (NANS)

The North American Neuromodulation Society (NANS) is the premier organization representing neuromodulation in the United States and is the largest member of the International Neuromodulation Society. NANS promotes multidisciplinary collaboration among clinicians, scientists, engineers, and others to advance neuromodulation therapies through education, rese...


CerebralRx

Based in Yehud, Israel, CerebralRx was founded in 2010 as a spin-off of BioControl Medical to develop breakthrough implantable neuromodulation systems for the treatment of autonomic nervous system-related neurological disorders. The company’s flagship product is the FitNeS system, an implantable vagus nerve stimulation device for treating patients wit...

Autonomic Systems LLC

Autonomic Technologies, Inc.

Privately held Autonomic Technologies, Inc., located in Redwood City, Calif., was founded in 2007. The company is backed by blue chip investors Kleiner Perkins, InterWest, Versant Ventures and Cleveland Clinic. For more information visit www.autonomictechnologies.com.

International Neuromodulation Society

The INS is a nonprofit group of clinicians, scientists and engineers dedicated to scientific development and knowledge of neuromodulation, a rapidly growing family of therapies developed to help relieve pain or restore function by delivering electromagnetic stimulation or chemical agents to specific sites in the body. Founded in 1989 and based in San Franc...

Functional Neuromodulation, Ltd

Founded in Toronto, Ontario in 2010, Functional Neuromodulation is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of people with Alzheimer’s and other memory and cognitive disorders. The Company has received funding from Genesys Capital, Foundation Medical Partners and Medtronic. ...

Cyberonics Sorin

Cyberonics, Inc. is a medical device company with core expertise in neuromodulation. The company developed and markets the VNS Therapy® System, which is FDA-approved for the treatment of medically refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the...

Immune Targeting Systems

Immune Targeting Systems is a London based biotech company developing vaccines for mutating viruses based on its broadly applicable next generation DepoVaccine and High Density (HD) Antigen identification technology platforms.

Functional Neuromodulation, Ltd.

Founded in Toronto, Ontario in 2010, Functional Neuromodulation is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of people with Alzheimer’s and other memory and cognitive disorders. The Company has received funding from Genesys Capital, Foundation Medical Partners and Medtronic. For more inf...

LivaNova PLC

LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healt...

Itamar-Medical Inc.

Itamar Medical Ltd. is a publicly-traded medical technology company (TASE: ITMR) utilizing PAT™ (Peripheral Arterial Tone) signal technology and applications. The PAT signal is a non-invasive "window" to both the cardiovascular and autonomic nervous systems.

Itamar-Medical Ltd

Itamar Medical Ltd. is a publicly-traded medical technology company (TASE: ITAMAR) utilizing PAT™ signal (Peripheral Arterial Tone) technology and applications. The PAT signal is a non-invasive "window" to both the cardiovascular and autonomic nervous systems.

Itamar Medical Ltd.

Itamar Medical Ltd. is a publicly-traded medical technology company utilizing PAT™ (Peripheral Arterial Tone) signal technology and applications. The PAT signal is a non-invasive "window" to both the cardiovascular and autonomic nervous systems. For more information, visit www.itamar-medical.com.

Immune Design Corp.

Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches to enable the body’s immune system to fight disease. The company’s technologies are engineered to activate the immune system’s natural ability to create and/or expand antigen-specific cytotoxic T cells, while enhancing other immune effectors,...

The GI Company, Inc

The GI Company is a privately held, specialty biopharmaceutical company established to meet the clinical needs and commercial opportunities available in the field of gastrointestinal medicine.The GI Company's strategy for success is to:Focus: Discover and develop products in key gastrointestinal indications with high medical need. Deliver: Identify and exploit "development-ready" technologies...

American Society for Gastrointestinal Endoscopy

Since its founding in 1941, the American Society for Gastrointestinal Endoscopy (ASGE) has been dedicated to advancing patient care and digestive health by promoting excellence in gastrointestinal endoscopy. ASGE, with more than 11,000 members worldwide, promotes the highest standards for endoscopic training and practice, fosters endoscopic research, recognizes distinguished contributions to endos...

Immune-Onc Therapeutics, Inc.

Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a newly established biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The Company is applying the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer pat...

PLx Pharma

PLx Pharma is a privately-owned pharmaceutical company developing proprietary formulations of proven nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, naproxen and ibuprofen which possess significantly improved gastrointestinal (GI) safety profiles. Based on PLx’s unique phospholipid based drug delivery technology, these products are desi...

Immune Targeting Systems (ITS) Ltd

Neurowave Medical Technologies

Neurowave Medical TechnologiesTM (NMT) is a rapidly growing, privately held Chicago-based medical device company that develops and manufactures transdermal neuromodulation devices for the treatment of a wide range of acute and chronic clinical conditions. Using its patented and proprietary neuromodulation technology platform, NMT’s mission is to take ...

DNAlite Therapeutics, Inc.

DNAlite Therapeutics, Inc. is an early-stage preclinical biotechnology company committed to bringing the next-generation of drugs to organs protected by mucosal barriers. DNAlite is currently developing a gene therapy strategy to treat monogenetic gastrointestinal diseases by delivering a functional copy of the gene to patients' gastrointestinal epithelium...

EndoGastric Solutions, Inc.

EndoGastric Solutions, Inc., is a pioneer in endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and other GI disorders. EGS’ mission is to utilize the most current wisdom in gastroenterology and surgery to develop new transoral procedures and products to address the largest unm...

Amazon Biotech

Amazon Biotech (OTCBB: AMZB) was established in 2003 to focus on the research and development of novel all-natural drugs for a better quality of life, by using the best of traditional medicines from the Amazon and Mother Nature. Amazon Biotech goal is to be a world leader and contributor in the treatment of HIV naturally through the use of Immune-based therapies (IBT). An Immune-Based Therapy i...


More From BioPortfolio on "VNS Prospective Neuromodulation of Autonomic, Immune and Gastrointestinal Systems"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks